<?xml version="1.0" encoding="UTF-8"?><!-- generator="WordPress/2.8" -->
<rss version="0.92">
<channel>
	<title>VyvanseInfo.com</title>
	<link>http://vyvanseinfo.com</link>
	<description>Everything you need to know about Vyvanse</description>
	<lastBuildDate>Wed, 10 Mar 2010 00:37:40 +0000</lastBuildDate>
	<docs>http://backend.userland.com/rss092</docs>
	<language>en</language>
	
	<item>
		<title>Study: Thousands of Israeli kids incorrectly prescribed Ritalin &#8211; Ha&#8217;aretz</title>
		<description>Study: Thousands of Israeli kids incorrectly prescribed RitalinHa'aretz... to Ritalin or Concerta and need medications not included in the government-subsidized "health basket," including Adderall, Vyvanse and Strattera. ... </description>
		<link>http://vyvanseinfo.com/study-thousands-of-israeli-kids-incorrectly-prescribed-ritalin-haaretz/</link>
			</item>
	<item>
		<title>US District Court upholds US FDA&#8217;s grant of 5 yrs market exclusivity to Vyvanse &#8211; pharmabiz.com</title>
		<description>US District Court upholds US FDA's grant of 5 yrs market exclusivity to Vyvansepharmabiz.comOn February 23, 2007, after reviewing the requisite clinical studies submitted on behalf of Vyanse, the US FDA determined that Vyvanse qualified as an NCE ... </description>
		<link>http://vyvanseinfo.com/us-district-court-upholds-us-fdas-grant-of-5-yrs-market-exclusivity-to-vyvanse-pharmabiz-com/</link>
			</item>
	<item>
		<title>US District Court upholds US FDA&#8217;s grant of 5 yrs market exclusivity to Vyvanse (PharmaBiz)</title>
		<description>Shire plc, the global specialty biopharmaceutical company, announced that the United States District Court for the District of Columbia, following extensive briefing by the parties and an oral hearing, has upheld the decision of the US Food and Drug Administration (US FDA) to grant five-year New Chemical Entity (NCE) exclusivity ...</description>
		<link>http://vyvanseinfo.com/us-district-court-upholds-us-fdas-grant-of-5-yrs-market-exclusivity-to-vyvanse-pharmabiz/</link>
			</item>
	<item>
		<title>District Court Upholds FDA&#8217;s Grant of 5-Year Market Exclusivity to VYVANSE(R) &#8211; PR-CANADA.net (press release)</title>
		<description>District Court Upholds FDA's Grant of 5-Year Market Exclusivity to VYVANSE(R)PR-CANADA.net (press release)On February 23, 2007, after reviewing the requisite clinical studies submitted on behalf of VYVANSE, the FDA determined that VYVANSE qualified as an NCE ... </description>
		<link>http://vyvanseinfo.com/district-court-upholds-fdas-grant-of-5-year-market-exclusivity-to-vyvanser-pr-canada-net-press-release/</link>
			</item>
	<item>
		<title>Actavis Loses to FDA in ADHD Drug Ruling &#8211; Courthouse News Service</title>
		<description>Actavis Loses to FDA in ADHD Drug RulingCourthouse News ServiceActavis Elizabeth LLC claimed that it should be able to sell its generic version of the ADHD drug, because Shire Pharmaceuticals' Vyvanse was not a "new ...Court rebuffs Actavis on Vyvanse FiercePharmaShire: District Court Upholds FDAs Grant of 5-Year Exclusivity Wall ...</description>
		<link>http://vyvanseinfo.com/actavis-loses-to-fda-in-adhd-drug-ruling-courthouse-news-service/</link>
			</item>
	<item>
		<title>BiomedReports: News and FDA Updates for Orexigen (Nasdaq:OREX), Shire (NASDAQ &#8230; &#8211; Trading Markets (press release)</title>
		<description>BiomedReports: News and FDA Updates for Orexigen (Nasdaq:OREX), Shire (NASDAQ ...Trading Markets (press release)... lisdexamfetamine dimesylate-currently marketed by Shire US Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R). ...and more&#160;&#187; </description>
		<link>http://vyvanseinfo.com/biomedreports-news-and-fda-updates-for-orexigen-nasdaqorex-shire-nasdaq-trading-markets-press-release/</link>
			</item>
	<item>
		<title>Traffic stop ends in drug bust (The Scottsboro Daily Sentinel)</title>
		<description>A Flat Rock man made bond Monday after being arrested over the weekend on drug charges, following a traffic stop. Chief Deputy Chuck Phillips said deputy Scott Flanagan made a traffic stop on County Road 139 in Bryant Sunday. </description>
		<link>http://vyvanseinfo.com/traffic-stop-ends-in-drug-bust-the-scottsboro-daily-sentinel-5/</link>
			</item>
	<item>
		<title>District Court Upholds FDA&#8217;s Grant Of 5-Year Market Exclusivity To VYVANSE® (BioresearchOnline)</title>
		<description>Shire plc (LSE: SHP, NASDAQ: SHPGY ), the global specialty biopharmaceutical company, announces that the United States District Court for the District of Columbia ("Court"), following extensive briefing by the parties and an oral hearing, has upheld the decision of the U.S. Food and Drug Administration ("FDA") to grant 5-year ...</description>
		<link>http://vyvanseinfo.com/district-court-upholds-fdas-grant-of-5-year-market-exclusivity-to-vyvanse%c2%ae-bioresearchonline/</link>
			</item>
	<item>
		<title>News and FDA Updates for Orexigen® (Nasdaq:OREX), Shire (NASDAQ:SHPGY) &#8211; American Chronicle</title>
		<description>News and FDA Updates for Orexigen® (Nasdaq:OREX), Shire (NASDAQ:SHPGY)American Chronicle... lisdexamfetamine dimesylate-currently marketed by Shire US Inc. for the treatment of attention-deficit hyperactivity disorder under the name VYVANSE(R).and more&#160;&#187; </description>
		<link>http://vyvanseinfo.com/news-and-fda-updates-for-orexigen%c2%ae-nasdaqorex-shire-nasdaqshpgy-american-chronicle/</link>
			</item>
	<item>
		<title>Aviva, Michael Page, Shire, WPP: U.K., Irish Equity Preview (Bloomberg)</title>
		<description>March 5 (Bloomberg) -- The following is a list of companies whose shares may have unusual price changes in U.K. and Irish markets today. Stock symbols are in parentheses and prices are from the last market close. </description>
		<link>http://vyvanseinfo.com/aviva-michael-page-shire-wpp-u-k-irish-equity-preview-bloomberg/</link>
			</item>
</channel>
</rss>
